David van Duin @davidvanduin

Infectious Diseases doc with interests in multi-drug resistant Gram-negative bacteria, and transplant, hem/onc, and burn patients. Opinions are my own. Joined February 2014

Tweets

5K
Followers

4K
Following

1K
Likes

3K

IDSA @IDSAInfo

2 years ago

A behind the scenes look at Tuesday’s congressional hearing on #antimicrobialresistance. Take action on the PASTEUR Act. Your voice will push Congress to create programs to help fight against AMR: idsociety.quorum.us/campaign/47463/ @GOPHELP @HELPCmteDems @hboucher3

0 2 13 4K 0

Download Video

IDWeek @IDWeekmtg

2 years ago

Whatever area of focus, whatever stage in your career, you belong here. Join your colleagues Oct. 11-15 in Boston for #IDWeek2023, the premier meeting for infectious diseases professionals. Register: idweek.org/registration

0 5 12 3K 0

Download Video

David van Duin @davidvanduin

2 years ago

Great work by @AndermannTessa and colleagues

Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward

2 years ago

Great work by @AndermannTessa and colleagues

1 12 39 9K 11

0 0 5 988 0

JAC-AMR @jac_amr

2 years ago

“Resistance of Acinetobacter baumannii to the recently available cefiderocol is concerning. Sulbactam/durlobactam is a promising option for MDR A. baumannii” Read the article by Tiseo et al: doi.org/10.1093/jacamr… @OUPMedicine @OxfordJournals #JACNews

0 10 26 3K 4

BSAC @BSACandJAC

2 years ago

Kakooza et al. report high prevalence of resistance to ciprofloxacin, tetracycline and benzylpenicillin, and emerging resistance determinants for azithromycin, in gonococcal isolates from African countries: doi.org/10.1093/jac/dk… @OUPMedicine @OxfordJournals #JACNews

1 1 1 727 0

IDSA @IDSAInfo

2 years ago

In 2019, an estimated 1.27 million deaths worldwide were directly caused by AMR, and AMR played a part in nearly 5 million deaths. US healthcare costs linked to infections from six of the biggest AMR threats total more than $4.6 billion annually, with $1.9 billion of these costs…

1 16 30 11K 1

Download Image

IDWeek @IDWeekmtg

2 years ago

The deadline is fast approaching to submit your team for IDBugBowl, the Jeopardy-style quiz game you know and love. Get your team together and submit your application by July 28: bit.ly/44wmRIo

0 5 14 5K 0

Download Image

HMH Infectious Disease Fellowships @HMH_IDfellow

2 years ago

ID BOARD REVIEW 45 YO M from Vietnam moved to the US 20 yrs ago s/p kidney Tx on tacrolimus & prednisone, c/o sudden headache & neck stiffness. LP done & CSF has 2000 WBC’s/mm3 (70% neutrophils), glucose of 10 mg/dl & gram stain has GNB’s. CSF Cx + for E.coli. Empiric Rx is:

3 3 7 4K 2

Adarsh Bhimraj @adarsh_bhimraj

2 years ago

Here is a brief twetorial on test taking strategies and how to approach a multiple choice question. New to posting twetorials & twitter threads, so would love feedback from Twitter gurus @PaulSaxMD @CarlosdelRio7 @davidvanduin @IDSAInfo

HMH Infectious Disease Fellowships @HMH_IDfellow

2 years ago

1 1 4 3K 1

Download Gif

1 2 8 2K 0

Barabas group @BarabasGroup

2 years ago

We are looking for PhD candidates🎓 to join our ERC Grant about the spread of antibiotic resistance. Dive into structural biology, biochemistry and microbiology in University of Geneva🇨🇭with cutting edge equipment for cryo-EM/ET and a beautifully place to work! please RT🔁

22 323 590 136K 138

Download Image

Arturo Casadevall @ACasadevall1

2 years ago

Long ago, the field of ID could have carved out paid niches in the interpretation of cultures, susceptibilities, etc. (like other specialties do). However, none of that happened and today the specialty can't attract sufficient fellows because other fields are more lucrative.

Brad Spellberg @BradSpellberg

2 years ago

1 1 13 43K 0

4 9 45 48K 1

David van Duin @davidvanduin

2 years ago

Nice work by Dylan Brown (starting Med school at ⁦@HofstraU⁩ in fall👍👍): Socioeconomic disparities in the prevalence of multidrug resistance in Enterobacterales | Infection Control & Hospital Epidemiology | Cambridge Core cambridge.org/core/journals/…

0 0 6 807 0

David van Duin @davidvanduin

2 years ago

Welcome to our new @UNC_ID fellows👍👍👍 @UNC @IDfellow_happy @UNCglobalhealth

0 7 35 3K 0

Download Image

JAC-AMR @jac_amr

2 years ago

We’re pleased to share our latest impact metrics: JAC-AMR was recently awarded a CiteScore™ (Scopus) of 3.8 & our first Impact Factor (Journal Citation Reports™) of 3.4 Thanks to all our authors, reviewers & Editors! academic.oup.com/jacamr/pages/A… @BSACandJAC @davidvanduin

1 11 31 5K 0

David van Duin @davidvanduin

2 years ago

WHO Global research agenda for antimicrobial resistance in human health who.int/publications/m…

0 2 5 1K 0

David Paterson @davidantibiotic

2 years ago

Continuous infusion Meropenem did not improve outcome in Critically Ill Patients With Sepsis - double blind RCT jamanetwork.com/journals/jama/…

5 78 227 49K 40

Camille Nelson Kotton @KottonNelson

2 years ago

@TxID_Fellows @AST_IDCOP @RicardoLaHozMD @AnnWoolleyMD This study looks to be quite well done; the authors say that “the results are not generalizable to patients who are immunocompromised”, in whom this can be a devastating, life-threatening infection. I have not had trouble giving four doses of ivermectin.